This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Dec 6;17(12):1567-9.

doi: 10.1038/nm.2583.

Improving the efficacy of translational medicine by optimally integrating health care, academia and industry

Stefan R Bornstein¹, Julio Licinio

Affiliations

PMID: 22146467
PMCID: PMC12180309
DOI: 10.1038/nm.2583

Improving the efficacy of translational medicine by optimally integrating health care, academia and industry

Stefan R Bornstein et al. Nat Med. 2011.

. 2011 Dec 6;17(12):1567-9.

doi: 10.1038/nm.2583.

Authors

Stefan R Bornstein¹, Julio Licinio

Affiliation

¹ University Clinic Carl-Gustav-Carus, Technical University, Dresden, Dresden, Germany. stefan.bornstein@uniklinikum-dresden.de

PMID: 22146467
PMCID: PMC12180309
DOI: 10.1038/nm.2583

No abstract available

PubMed Disclaimer

Conflict of interest statement

COMPETING FINANCIAL INTERESTS

The authors declare no competing financial interests.

Similar articles

Academia-pharma partnerships for novel drug discovery: essential or nice to have?
Palmer M, Chaguturu R. Palmer M, et al. Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17. Expert Opin Drug Discov. 2017. PMID: 28394189 No abstract available.
Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
Patel AC, Coyle AJ. Patel AC, et al. Clin Pharmacol Ther. 2013 Sep;94(3):314-6. doi: 10.1038/clpt.2013.89. Epub 2013 May 3. Clin Pharmacol Ther. 2013. PMID: 23645247 No abstract available.
Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.
Thomas CJ, McKew JC. Thomas CJ, et al. Curr Top Med Chem. 2014;14(3):291-3. doi: 10.2174/1568026613666131127125351. Curr Top Med Chem. 2014. PMID: 24283974 Free PMC article. No abstract available.
Leveraging public private partnerships to innovate under challenging budget times.
Portilla LM, Rohrbaugh ML. Portilla LM, et al. Curr Top Med Chem. 2014;14(3):326-9. doi: 10.2174/1568026613666131127155703. Curr Top Med Chem. 2014. PMID: 24283971 Free PMC article. Review.
Open PHACTS: semantic interoperability for drug discovery.
Williams AJ, Harland L, Groth P, Pettifer S, Chichester C, Willighagen EL, Evelo CT, Blomberg N, Ecker G, Goble C, Mons B. Williams AJ, et al. Drug Discov Today. 2012 Nov;17(21-22):1188-98. doi: 10.1016/j.drudis.2012.05.016. Epub 2012 Jun 7. Drug Discov Today. 2012. PMID: 22683805 Review.

See all similar articles

Cited by

Translational research policies: disruptions and continuities in biomedical innovation systems in Austria, Finland and Germany.
Vignola-Gagné E, Rantanen E, Lehner D, Hüsing B. Vignola-Gagné E, et al. J Community Genet. 2013 Apr;4(2):189-201. doi: 10.1007/s12687-012-0130-0. Epub 2012 Dec 29. J Community Genet. 2013. PMID: 23275179 Free PMC article.
Developing translational medicine professionals: the Marie Skłodowska-Curie action model.
Petrelli A, Prakken BJ, Rosenblum ND; EUtrain fellows. Petrelli A, et al. J Transl Med. 2016 Nov 29;14(1):329. doi: 10.1186/s12967-016-1088-1. J Transl Med. 2016. PMID: 27899114 Free PMC article.
Clinical classification in mental health at the cross-roads: which direction next?
Hickie IB, Scott J, Hermens DF, Scott EM, Naismith SL, Guastella AJ, Glozier N, McGorry PD. Hickie IB, et al. BMC Med. 2013 May 14;11:125. doi: 10.1186/1741-7015-11-125. BMC Med. 2013. PMID: 23672522 Free PMC article.
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine.
Masucci M, Karlsson C, Blomqvist L, Ernberg I. Masucci M, et al. J Pers Med. 2024 May 24;14(6):561. doi: 10.3390/jpm14060561. J Pers Med. 2024. PMID: 38929782 Free PMC article. Review.
Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.
Zhang Z, Zhang G, Sun Y, Szeto SS, Law HC, Quan Q, Li G, Yu P, Sho E, Siu MK, Lee SM, Chu IK, Wang Y. Zhang Z, et al. Sci Rep. 2016 Nov 14;6:37148. doi: 10.1038/srep37148. Sci Rep. 2016. PMID: 27841332 Free PMC article.

See all "Cited by" articles

References

1. Coller BS & Califf RM Sci. Transl. Med 1, 10cm9 (2009). - PMC - PubMed
1. Licinio J Transl. Psychiatr 1, e1 (2011). - PMC - PubMed
1. Finkbeiner S Nat. Med 16, 1227–1232 (2010). - PubMed
1. Anonymous. Nat. Med 16, 1200 (2010).
1. Albani S & Prakken B Nat. Med 15, 1006–1009 (2009). - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K24 RR016996/RR/NCRR NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central
Medical
- MedlinePlus Health Information